Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy by Kenneth K. H. Lai, Fatema Mohamed Ali Abdulla Aljufairi, Chi Lai Li, Amanda K. Y. Ngai, Carly S. K. Yeung, Ryan H. Y. Fong, Wilson W. K. Yip, Alvin L. Young, Chi Pui Pang, Kelvin K. L. Chong

Get full text